Patients with HIV with Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the highly active antiretroviral therapy era

被引:19
作者
Buzdar, AU [1 ]
Hunt, KK
Berry, D
Hortobagyi, GN
机构
[1] Natl Canc Inst, Div Med Oncol A, Aviano, Italy
[2] Natl Canc Inst, Epidemiol Unit, Aviano, Italy
关键词
D O I
10.1200/JCO.2005.02.9561
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:8132 / 8133
页数:2
相关论文
共 2 条
[1]   AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: Significant differences in survival with standard chemotherapy [J].
Lim, ST ;
Karim, R ;
Nathwani, BN ;
Tulpule, A ;
Espina, B ;
Levine, AM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) :4430-4438
[2]   Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials [J].
Spina, M ;
Jaeger, U ;
Sparano, JA ;
Talamini, R ;
Simonelli, C ;
Michieli, M ;
Rossi, G ;
Nigra, E ;
Berretta, M ;
Cattaneo, C ;
Rieger, AC ;
Vaccher, E ;
Tirelli, U .
BLOOD, 2005, 105 (05) :1891-1897